These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24591918)

  • 21. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
    Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome.
    Gustofson RL; Segars JH; Larsen FW
    Hum Reprod; 2006 Nov; 21(11):2830-7. PubMed ID: 16966348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
    Fauser BC; de Jong D; Olivennes F; Wramsby H; Tay C; Itskovitz-Eldor J; van Hooren HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):709-15. PubMed ID: 11836309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas.
    Losa M; Ciccarelli E; Mortini P; Barzaghi R; Gaia D; Faccani G; Papotti M; Mangili F; Terreni MR; Camanni F; Giovanelli M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5194-200. PubMed ID: 11701676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor.
    Gründker C; Schlotawa L; Viereck V; Eicke N; Horst A; Kairies B; Emons G
    Eur J Endocrinol; 2004 Jul; 151(1):141-9. PubMed ID: 15248835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.
    Fluker M; Grifo J; Leader A; Levy M; Meldrum D; Muasher SJ; Rinehart J; Rosenwaks Z; Scott RT; Schoolcraft W; Shapiro DB;
    Fertil Steril; 2001 Jan; 75(1):38-45. PubMed ID: 11163814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro.
    Imai A; Takagi A; Tamaya T
    Am J Obstet Gynecol; 2000 May; 182(5):1142-6. PubMed ID: 10819849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural elucidation of Leuprolide and its analogues in solution: insight into their bioactive conformation.
    Laimou DK; Katsara M; Matsoukas MT; Apostolopoulos V; Troganis AN; Tselios TV
    Amino Acids; 2010 Nov; 39(5):1147-60. PubMed ID: 20354741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that the main adverse effect of ganirelix on pregnancy and implantation rates is on the embryo rather than the endometrium.
    Check JH; Cohen R; Amui J; Choe JK; Brasile D
    Clin Exp Obstet Gynecol; 2011; 38(4):326-7. PubMed ID: 22268265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HOXA10 protein expression in the endometrium of normally menstruating women after receiving GnRH antagonist.
    Sirayapiwat P; Triratanachat S; Tantbirojn P; Ruangvejvorachai P; Suwajanakorn S
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):321-5. PubMed ID: 23541416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells.
    Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
    Int J Oncol; 1998 Jul; 13(1):97-100. PubMed ID: 9625809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization.
    Posada MN; Vlahos NP; Jurema MW; Bracero NJ; Wallach EE; Garcia JE
    Fertil Steril; 2003 Jul; 80(1):103-10. PubMed ID: 12849810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
    Kim YA; Kim MR; Lee JH; Kim JY; Hwang KJ; Kim HS; Lee ES
    Gynecol Obstet Invest; 2009; 68(2):73-81. PubMed ID: 19401614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study.
    Grow DR; Williams RF; Hsiu JG; Hodgen GD
    J Clin Endocrinol Metab; 1996 May; 81(5):1933-9. PubMed ID: 8626860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression.
    Cucchiara V; Yang JC; Liu C; Adomat HH; Tomlinson Guns ES; Gleave ME; Gao AC; Evans CP
    Mol Cancer Ther; 2019 Oct; 18(10):1811-1821. PubMed ID: 31341032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders.
    Schmidt DW; Bremner T; Orris JJ; Maier DB; Benadiva CA; Nulsen JC
    Fertil Steril; 2005 May; 83(5):1568-71. PubMed ID: 15866609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of pregnancy rates following fresh and frozen embryo transfer according to the use of leuprolide acetate vs ganirelix vs cetrorelix.
    Check JH; Wilson C; Choe JK; Amui J; Katsoff B
    Clin Exp Obstet Gynecol; 2010; 37(2):105-7. PubMed ID: 21077496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of gonadotropin-releasing hormone agonist and antagonist on proliferation and apoptosis of human luteinized granulosa cells.
    Vitale AM; Abramovich D; Peluffo MC; Meresman G; Tesone M
    Fertil Steril; 2006 Apr; 85(4):1064-7. PubMed ID: 16580402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.